HORIBA Medical, specialists in automated in vitro diagnostic systems for hematology, hemostasis and clinical chemistry analysis, has obtained the CE…

This time we focus on the Thrombotic Thrombocytopenic Purpura (TTP), an acute disorder characterised by thrombocytopenia and mircoangiopathic…

HORIBA Medical has obtained U.S. FDA and Health Canada clearance in North America for its next generation clinical chemistry system, the Yumizen…

Click here to open the newsletter #6 

QSP 2.0: An Affordable Digital tool for “Skills Evaluation & Training” in blood morphology

Montpellier and Grenoble, France, July 21, 2020

HORIBA Medical, a subsidiary of Japan-based HORIBA Group, the global leader for measurement and…

HORIBA Medical has established a partnership with BioMedica Diagnostics Inc. (BMD)